TEDA BIOMEDICAL (08189) has announced the signing of a strategic cooperation framework agreement with Hunan Xingchen Universal Robot Co., Ltd. (referred to as "Xingchen Universal").
Under the terms of this partnership, both entities will adhere to principles of equality, mutual benefit, complementary advantages, scenario-driven innovation, resource sharing, and long-term collaboration. Their joint focus will be on the deep integration of healthcare large models with embodied intelligence technology, working together to advance the development and industrial deployment of a medical-health embodied intelligence technology system, product portfolio, and comprehensive solutions.
The board believes that merging healthcare large models with embodied intelligence technology marks a pivotal step in evolving artificial intelligence beyond information comprehension, knowledge-based Q&A, and decision support toward real-world environmental perception, physical interaction, and task execution. The company has long maintained a strategic focus on healthcare technology, intelligent medical applications, and related industrial ventures. It possesses robust capabilities in the research, operation, and continuous iteration of healthcare large models, specialized medical agents, medical knowledge frameworks, and associated algorithms. This enables the company to leverage professional medical expertise, operational workflows, service demands, and application scenarios to facilitate the deployment of healthcare large models and intelligent agents across health consultations, patient navigation, health management, elder care and rehabilitation, public health initiatives, and healthcare institution operations.
Xingchen Universal, on the other hand, is a high-tech enterprise centered on full-stack embodied intelligence technology and the development of core robotic hardware platforms. It is dedicated to constructing a "one brain, multiple bodies" robotic technology ecosystem. The company possesses comprehensive capabilities in robot bodies, intelligent hardware, edge-side intelligent systems, multi-sensor fusion, navigation and positioning, motion control, robotic skill development, product engineering, and scenario deployment, enabling the deep integration of models, agents, and robotic terminals to perform perception, interaction, mobility, and task execution in real-world environments.
The two parties demonstrate strong complementarity in these domains. Through this strategic collaboration, TEDA BIOMEDICAL can deeply combine its core strengths in healthcare large models, specialized vertical agents, and medical knowledge systems with Xingchen Universal's embodied intelligent robots, smart hardware, and scenario deployment abilities. Together, they aim to forge a medical-health embodied intelligence technology system, product suite, and solutions, establishing a closed-loop framework encompassing "data collection and governance, model and agent development, terminal adaptation, pilot-scale validation, scenario application, operational feedback, continuous iteration, and industrial promotion."
This initiative is expected to, on one hand, facilitate the extension of healthcare large models and intelligent agents from the digital realm into the physical world, accelerating the large-scale adoption of high-quality projects across hospitals, primary care facilities, community health centers, elder care and rehabilitation institutions, home health settings, and public health scenarios. On the other hand, it stands to broaden the group's business scope within AI-driven healthcare, healthcare large models, and embodied intelligence, thereby enhancing its technical expertise, product competitiveness, and market influence in the medical AI sector, laying a solid foundation for the group's sustainable, high-quality growth over the long term.